BIOMAT Database Logo BIOMAT Database Logo

A theory of the action of cancer chemotherapeutic drugs. 1967

S Rose

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

S Rose
[Reciprocal action of chemotherapeutic drugs and antibiotic].
January 1954, Archiv fur klinische und experimentelle Dermatologie,
S Rose
Reflection on the mechanism of action of chemotherapeutic drugs.
May 1947, Science (New York, N.Y.),
S Rose
[Mechanisms of action of chemotherapeutic drugs--microcalorimetric studies].
March 1989, Wiener klinische Wochenschrift,
S Rose
[On the mechanism of action of antibiotics and chemotherapeutic drugs].
April 1966, Der Landarzt,
S Rose
The role of MAPK pathways in the action of chemotherapeutic drugs.
November 2002, Carcinogenesis,
S Rose
Chemotherapeutic Theory.
March 1940, British medical journal,
S Rose
Anaesthesia and anti-cancer chemotherapeutic drugs.
June 2005, Current opinion in anaesthesiology,
S Rose
Studies on the mechanism of action of chemotherapeutic agents in cancer. VI. Synergistic (additive) action of drugs on a transplantable leukemia in mice.
January 1952, Cancer,
S Rose
[The mechanism of action of chemotherapeutic substances against cancer].
January 1960, Suvremenna meditsina,
S Rose
Chemotherapeutic drugs; a review.
December 1949, Annals of the Royal College of Surgeons of England,
Copied contents to your clipboard!